NASDAQ · Financial Statements

Klotho Neurosciences, Inc. (KLTO) Financial Statements

$0.38 NASDAQ: KLTO Market Cap $20.08M

Klotho Neurosciences, Inc. most recently reported annual revenue of $0, net profit of $-11.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-1.0M$-6.0M$-7.0M
Net Profit$-1.0M$-1.0M$-1.0M$-6.0M$-11.0M
EPS$0.00$0.00$0.00$-0.32$-0.22
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$3.0M$2.0M$2.0M$10.0M
Total Liabilities$0$1.0M$2.0M$1.0M$0
Cash$0$0$0$0$7.0M
Borrowings$0$1.0M$1.0M$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$0$-3.0M$-6.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$0$0$0$0$7.0M
Free Cash Flow$0$-1.0M$0$-3.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.08
EV / EBITDA-0.67
FCF Yield-47.81%
Quick Ratio19.74
Interest Coverage-5.13
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
KLTO Overview KLTO Dividend Run Stock Screener